XML 46 R36.htm IDEA: XBRL DOCUMENT v3.21.1
Employee Benefits and Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation Expense
The following table sets forth the total share-based compensation expense recognized in the Company’s Condensed Consolidated Statements of Operations for the three months ended March 31, 2021 and 2020:
Three Months Ended March 31,
20212020
(In thousands)
Cost of product and service revenues$1,937 $1,770 
Research and development1,700 1,768 
Selling, general, and administrative8,135 7,121 
Total share-based compensation expense$11,772 $10,659 
Assumptions Used to Value Stock Options Granted
The following assumptions were used to value stock options and Employee Stock Purchase Plan (“ESPP”) shares granted pursuant to the Company’s equity incentive plans for the three months ended March 31, 2021 and 2020:
Three Months Ended March 31,
20212020
Stock options
Expected life, years 4.94.7
Expected volatility, % 30.1 %33.6 %
Risk-free interest rate, % 0.6 %1.4 %
Estimated forfeiture rate, %7.9 %5.7 %
Dividend yield, % — %— %
Assumptions Used to Value ESPP Shares Granted
Three Months Ended March 31,
20212020
Employee stock purchase plan shares
Expected life, years
0.5 - 2.0
0.5 - 2.0
Expected volatility, %
27.4% - 53.5%
30.4% - 39.9%
Risk-free interest rate, %
0.1% - 2.6%
1.4% - 2.7%
Dividend yield, % — %— %
Summary of Share Option Activity
The following table summarizes the share option activity under the Company’s 2009 Equity Incentive Plan (the “2009 Plan”), as amended, during the three months ended March 31, 2021:
Number of
Shares
Weighted-Average
Exercise Price
Weighted-Average
Remaining Years
Aggregate
Intrinsic Value
(In thousands, except per share data)
Outstanding at December 31, 20203,932 $62.50 7.8$226,160 
Granted150 125.80 
Exercised(196)58.49 
Expired(6)78.32 
Forfeited(60)72.27 
Outstanding at March 31, 20213,820 $65.02 7.5$247,796 
Exercisable at March 31, 20211,608 $47.83 5.8$131,946 
Vested and expected to vest at March 31, 2021 and thereafter3,598 $64.01 7.4$237,072 
Summary of Restricted Stock Unit Activity
Summaries of the restricted stock activity under the 2009 Plan are presented below for the three months ended March 31, 2021:
Number of
Shares
Weighted-Average
Grant Date Fair Value
Weighted-Average
Remaining Years
Aggregate
Intrinsic Value
(In thousands, except per share data)
Restricted stock units
Outstanding at December 31, 2020580 $72.87 1.6$69,670 
Granted (Awarded)96 129.97 
Vested (Released)(37)72.71 
Forfeited(17)70.59 
Outstanding and unvested at March 31, 2021622 $81.79 1.6$80,723 
Summary of Restricted Stock Awards Activity
Number of
Shares
Weighted-Average
Grant Date Fair Value
(In thousands, except per share data)
Restricted stock awards
Outstanding at December 31, 202021 $68.11 
Granted (Awarded)— — 
Vested (Released)— — 
Outstanding and unvested at March 31, 202121 $68.11 
Summary of Performance-Based Restricted Stock Activity
A summary of the performance-based restricted stock activity under the 2009 Plan is presented below for the three months ended March 31, 2021:
Number of
Shares
Weighted-Average
Grant Date Fair Value Per Unit
(In thousands, except per share data)
Outstanding at December 31, 2020155 $74.26 
Granted51 156.79 
Vested(17)82.35 
Forfeited(6)63.20 
Outstanding and unvested at March 31, 2021183 $96.94 
Ordinary Shares Reserved for Future Issuance Under Equity Incentive Plans
The Company had the following ordinary shares reserved for future issuance under its equity incentive plans as of March 31, 2021:
Number of Shares
(In thousands)
Share options outstanding3,820 
Non-vested restricted stock awards826 
Shares authorized for future issuance872 
ESPP shares available for future issuance1,050 
Total shares reserved for future issuance6,568